These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 19278835)

  • 1. Tigecycline possibly underdosed for the treatment of pneumonia: a pharmacokinetic viewpoint.
    Burkhardt O; Rauch K; Kaever V; Hadem J; Kielstein JT; Welte T
    Int J Antimicrob Agents; 2009 Jul; 34(1):101-2. PubMed ID: 19278835
    [No Abstract]   [Full Text] [Related]  

  • 2. Tigecycline for the treatment of patients with community-acquired pneumonia requiring hospitalization.
    Falagas ME; Metaxas EI
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):913-23. PubMed ID: 19803699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
    Koomanachai P; Kim A; Nicolau DP
    J Antimicrob Chemother; 2009 May; 63(5):982-7. PubMed ID: 19279050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
    Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline use in critically ill older patients: case reports and critical analysis.
    Curcio D; Fernández F; Duret F
    J Am Geriatr Soc; 2007 Feb; 55(2):312-3. PubMed ID: 17302676
    [No Abstract]   [Full Text] [Related]  

  • 6. Tigecycline: a single antibiotic for polymicrobial infections.
    Pankey GA; Steele RW
    Pediatr Infect Dis J; 2007 Jan; 26(1):77-8. PubMed ID: 17195711
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tigecycline as a treatment for pneumonia].
    Domínguez I
    Rev Chilena Infectol; 2013 Dec; 30(6):598. PubMed ID: 24522300
    [No Abstract]   [Full Text] [Related]  

  • 8. Should tigecycline be considered for urinary tract infections? A pharmacokinetic re-evaluation.
    Nix DE; Matthias KR
    J Antimicrob Chemother; 2010 Jun; 65(6):1311-2. PubMed ID: 20378673
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of effect of extracorporeal membrane oxygenation on tigecycline pharmacokinetics.
    Veinstein A; Debouverie O; Grégoire N; Goudet V; Adier C; Robert R; Couet W
    J Antimicrob Chemother; 2012 Apr; 67(4):1047-8. PubMed ID: 22207598
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline.
    Bhavnani SM; Rubino CM; Hammel JP; Forrest A; Dartois N; Cooper CA; Korth-Bradley J; Ambrose PG
    Antimicrob Agents Chemother; 2012 Feb; 56(2):1065-72. PubMed ID: 22143524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline pharmacokinetic/pharmacodynamic update.
    MacGowan AP
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i11-6. PubMed ID: 18684702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia.
    Tanaseanu C; Bergallo C; Teglia O; Jasovich A; Oliva ME; Dukart G; Dartois N; Cooper CA; Gandjini H; Mallick R; ;
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):329-38. PubMed ID: 18508226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium chelonae necrotizing pneumonia after allogeneic hematopoietic stem cell transplant: report of clinical response to treatment with tigecycline.
    Peres E; Khaled Y; Krijanovski OI; Mineishi S; Levine JE; Kaul DR; Riddell J
    Transpl Infect Dis; 2009 Feb; 11(1):57-63. PubMed ID: 18983415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline.
    Prescrire Int; 2007 Dec; 16(92):245. PubMed ID: 18092414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic efficacy, animal models and experimental pharmacodynamics: what do we know about tigecycline?].
    Giménez MJ; Barberán J; Aguilar L
    Rev Esp Quimioter; 2007 Dec; 20(4):387-94. PubMed ID: 18563212
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tigecycline, the first of a new class of antibiotics: the glycylcyclines].
    Bosó-Ribelles V; Roma-Sánchez E; Salavert-Lletí M; Hernández-Martí V; Poveda-Andrés JL
    Rev Esp Quimioter; 2007 Mar; 20(1):19-35. PubMed ID: 17530033
    [No Abstract]   [Full Text] [Related]  

  • 17. Tigecycline in critical care.
    Mullangi PK; Pankey GA
    Crit Care Clin; 2008 Apr; 24(2):365-75, x. PubMed ID: 18361951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The yield of tigecycline in the treatment of community-acquired pneumonia].
    Cilli A
    Tuberk Toraks; 2013; 61(2):155-61. PubMed ID: 23875595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered bioavailability of tacrolimus following intravenous administration of tigecycline.
    Pavan M; Chaudhari AP; Ranganth R
    Am J Kidney Dis; 2011 Feb; 57(2):354. PubMed ID: 21251548
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid penetration of tigecycline.
    Pallotto C; Fiorio M; D'Avolio A; Sgrelli A; Baldelli F; Di Perri G; De Socio GV
    Scand J Infect Dis; 2014 Jan; 46(1):69-72. PubMed ID: 24131423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.